Combined antiretroviral and anti-tuberculosis drug resistance following incarceration

South Afr J HIV Med. 2013 Sep 1;14(3):10.7196/SAJHIVMED.957. doi: 10.7196/SAJHIVMED.957.

Abstract

We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework.